Single Lane Sequencing is now available for NovaSeq X Plus!

img-hero-text

From the world’s first human genome to our 720,000th, we’ve been delivering quality at scale for more than 15 years.

Bullseye LLC, offers services to power your multi-omic data generation and analysis needs, across a range of research, translational, and clinical Dx applications.

RNA Sequencing starting at $399

Single Cell Sequencing starting at $120

We aim to accelerate the

understanding diagnosis treatment of disease

Services

Bullseye develops and offers impactful services to the world, powers transformative projects, and drives adoption of the latest technologies and novel molecular assays. With 15+ years of expertise and partnership with thought leaders in the research community and beyond, you can trust us to deliver dependable, advanced multi-omic services at competitive prices.

RNA Sequencing

Single Cell (10x GEX and Multiome, Smart-Seq2)

Whole Genome Sequencing

Sequencing of Customer-Prepared Libraries​

Blended Genome-Exome Sequencing

Whole Exome Sequencing

RNA Sequencing​

Single Cell (10X GEX and Multiome, Smart-Seq2)

Plasma Proteomic Profiling

MAS-seq

Liquid Biopsy

Microbial Whole Genome Sequencing

Featured Service:

Clinical Blended Genome- Exome Sequencing

Blended Genome Exome (BGE) is a qualitative assay that combines low pass genome and deeper exome sequencing of single nucleotide variants (SNVs) and small insertions and deletions (InDels) in human genome DNA extracted from saliva and blood samples. BGE is ideal for large scale germline gene-disease discovery studies where the low pass genome region is used as an unbiased alternative to microarray genotyping in GWAS applications and the clinical depth exome is used for gene panels for monogenic conditions.

img-featured-service-3

Featured Service:

Sequencing of Customer-Prepared Libraries (Walk-Up Sequencing)

Need rapid turnaround sequencing for your pre-constructed libraries and library pools? Our convenient Walk-Up Sequencing (WUS) service provides access to the latest sequencing technologies – including the Illumina® NovaSeq X Plus, PacBio Revio™, and Ultima Genomics UG 100™ – operated by expert staff, whether you “walk up” to drop libraries off in person or ship them to our facility.

Sequencing of Customer-Prepared Libraries (Walk-Up Sequencing)

Delivering quality at scale for over 15 years

Whole Genomes
Sequenced

>720,000

Genomic Specimens
Received and
Processed

>3 million

Whole Exomes
Sequenced

>800,000

Genomic Data
Produced

>100 petabases

Blended Genome-
Exomes sequenced

>200,000

Clinical Diagnostic
Tests Returned
(includes COVID-19
testing)

>37 million

Whole Genomes
Sequenced

>650,000

Whole Exomes
Sequenced

>800,000

Blended Genome-
Exomes sequenced

>150,000

Genomic Specimens Received and Processed

>3 million

Genomic Data Produced

>95 petabases

Clinical Diagnostic
Tests Returned
(includes COVID-19
testing)

>37 million

Get started with our laboratory at Bullseye

Step 1

Tell us about your sequencing needs

Step 2

Coordinate with a Project Manager

Step 3

Submit your
samples

Step 4

Receive results through cloud data platform

Blended Genome-Exome Sequencing

Blended Genome-Exome Sequencing

Sean Hofherr

Chief of Clinical Strategy and Product Development, Broad Clinical Labs

Sean Hofherr is dual board certified by ABMGG in Clinical Biochemical Genetics and Clinical Molecular Genetics. Sean serves as the Chief of Clinical Strategy and Product Development at Broad Clinical Labs. In this role at BCL, Sean is able to leverage his extensive experience to guide the clinical vision and delivery across the organization. Sean most recently served as the Chief Operating Office at Fabric Genomics, which focuses on the use of AI and Bioinformatics for Clinical Interpretation of whole genome sequencing. Prior to Fabric, Sean was the Chief Scientific Officer and CLIA Director at the commercial reference laboratory, GeneDx.

Sean received his B.S. degree in Microbiology and Cell Sciences from the University of Florida before earning his Ph.D. in Molecular and Human Genetics from Baylor College of Medicine. Sean completed clinical fellowships in Clinical Biochemical Genetics and Clinical Molecular Genetics at the Mayo Clinic.

Danielle Perrin

Chief of Staff, Broad Clinical Labs

Tim De Smet

As Chief Operating Officer, Sheila Dodge leads Broad Clinical Labs’ process development and implementation activities, as well as lab operations, financial planning and operations, quality & compliance, and core business processes. A Six Sigma Black Belt with extensive experience in process development and high throughput genomics operations, Dodge is an expert in work design and in collaborating with a range of collaborators, scientists, engineers, and technology partners to rapidly integrate new technologies and operationalize innovations. A member of the Broad Institute since 2001, Dodge is an Institute Scientist and lectures at the MIT Sloan School of Management on operations, dynamic work design, and visual management techniques.